Franklin Genomic Advancements

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HELX and other ETFs, options, and stocks.

About HELX

HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. The listed name for HELX is Franklin Genomic Advancements ETF. 

Index-Tracked
Index-Tracked
Category
Health
CategoryHealth
Number of holdings
67
Number of holdings67
Inception Date
Feb 25, 2020
Inception DateFeb 25, 2020

What's in this fund

Sectors

As of July 4, 2025
Healthcare94.07%
Basic Materials3.48%
Technology2.45%

Top 10 Holdings (38.86% of total assets)

As of July 4, 2025
NameSymbol% Assets
NateraNTRA6.31%
Vertex PharmaceuticalsVRTX4.23%
Samsung BioLogics Co Ltd207940 (XKRX)4.23%
Guardant HealthGH3.84%
Alnylam PharmaceuticalsALNY3.78%
Krystal BiotechKRYS3.46%
CortevaCTVA3.40%
MedpaceMEDP3.25%
Eli LillyLLY3.19%
Insmed IncorporatedINSM3.17%

HELX Key Statistics

AUM
11.25M
AUM11.25M
Price-Earnings ratio
-137.64
Price-Earnings ratio-137.64
30-Day yield
—
30-Day yield—
Average volume
3.52K
Average volume3.52K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$33.98
52 Week high$33.98
52 Week low
$23.74
52 Week low$23.74
Expense ratio
0.50
Expense ratio0.50
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.